Inflaforte

Diclofenac sodium, the active ingredient in Inflaforte, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for external use. It provides relief of musculoskeletal pain and is used in conditions such as osteoarthritis and rheumatoid arthritis.

GNH USA supplies Inflaforte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inflaforte (diclofenac sodium) is applied to the skin to reduce inflammation and pain in musculoskeletal disorders.

- Musculoskeletal pain: alleviates localized pain and improves joint function. - Osteoarthritis: reduces joint inflammation and stiffness in affected joints. - Rheumatoid arthritis: helps control inflammatory symptoms in peripheral joints.

Topical diclofenac may cause skin‑related reactions and, in rare cases, systemic adverse events.

Common Side Effects: - Skin irritation: redness or burning at the application site. - Itching: mild pruritus where the gel is applied. - Dryness: localized skin dryness or flaking.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Stevens‑Johnson syndrome: rare but serious skin blistering. - Hepatic or renal impairment: abnormal liver or kidney function tests.

Before using Inflaforte, consider the following precautions to ensure safe and effective therapy.

- Assess renal function: avoid use in patients with severe renal impairment. - Monitor hepatic enzymes: discontinue if liver function deteriorates. - Avoid application on infected or broken skin: may increase systemic absorption. - Limit application area: do not exceed the recommended surface area per day. - Do not combine with systemic NSAIDs: increased risk of gastrointestinal bleeding. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Inflaforte can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Concurrent systemic NSAIDs: heightened risk of gastrointestinal bleeding and renal toxicity. - Anticoagulants (e.g., warfarin): increased potential for bleeding complications. - Selective COX‑2 inhibitors: additive cardiovascular and renal risks.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal function when combined. - ACE inhibitors or ARBs: may impair renal perfusion. - Lithium: diclofenac can raise lithium serum concentrations.